Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 0 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
SEQ-400
SEQ-400 is a vaccine against urinary tract infections (UTIs) which is under development for potential medical use. It is a vaccine against the Escherichia coli FimH adhesin protein, which is essential for bacterial infection. The vaccine is being developed by Sequoia Sciences. As of September 2023, it is in phase 2 clinical trials. SEQ-400 is being developed for potential approval and use in the United States.
SEQ-400
SEQ-400 is a vaccine against urinary tract infections (UTIs) which is under development for potential medical use. It is a vaccine against the Escherichia coli FimH adhesin protein, which is essential for bacterial infection. The vaccine is being developed by Sequoia Sciences. As of September 2023, it is in phase 2 clinical trials. SEQ-400 is being developed for potential approval and use in the United States.